Kintara Therapeutics Inc

NASDAQ:KTRA   3:59:48 PM EDT
0.65
+0.05 (+7.67%)
Earnings Announcements

Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results

Published: 11/15/2021 14:02 GMT
Kintara Therapeutics Inc (KTRA) - Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update.
Q1 Loss per Share $0.25.
Enrollment of First Patient in 15-patient Confirmatory Study of Rem-001 is Expected in Q2 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.